QS Investors, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 294 filers reported holding NEKTAR THERAPEUTICS in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2020$107,000
+28.9%
4,6000.0%0.00%0.0%
Q1 2020$83,000
-14.4%
4,6000.0%0.00%0.0%
Q4 2019$97,000
-17.8%
4,600
-28.7%
0.00%0.0%
Q3 2019$118,000
-48.7%
6,4500.0%0.00%
-50.0%
Q2 2019$230,000
+6.0%
6,4500.0%0.00%0.0%
Q1 2019$217,000
+1.9%
6,450
-0.2%
0.00%
-33.3%
Q4 2018$213,000
-89.4%
6,462
-80.4%
0.00%
-84.2%
Q3 2018$2,010,000
+24.8%
32,9650.0%0.02%
+18.8%
Q2 2018$1,610,000
+177.6%
32,965
+503.5%
0.02%
+166.7%
Q1 2018$580,000
+168.5%
5,462
+51.2%
0.01%
+200.0%
Q4 2017$216,000
+151.2%
3,612
+0.3%
0.00%
+100.0%
Q3 2017$86,000
+22.9%
3,6000.0%0.00%0.0%
Q2 2017$70,000
-17.6%
3,600
-0.7%
0.00%0.0%
Q1 2017$85,000
+8400.0%
3,626
+13846.2%
0.00%
Q4 2016$1,0000.0%260.0%0.00%
Q3 2016$1,0000.0%26
+44.4%
0.00%
Q2 2016$1,000
-99.8%
18
-99.9%
0.00%
-100.0%
Q4 2015$561,000
+53.7%
33,286
+0.1%
0.01%
+25.0%
Q3 2015$365,000
-13.1%
33,269
-0.9%
0.00%
-20.0%
Q2 2015$420,000
+13.5%
33,5580.0%0.01%
+25.0%
Q1 2015$370,000
-28.3%
33,558
+0.9%
0.00%
-33.3%
Q4 2014$516,00033,2690.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2019
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders